Introduction to the Glucose Sensing Problem

In Vivo Glucose Sensing

Volumn , Issue , 2009, Pages 1-27

  Wilson, George S ^a   Zhang, Yanan ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Chemical methods for glucose measurement; Glucose biosensors for clinical applications; Glucose sensing problem and glucose monitoring systems (nonelectrochemical)

Indexed keywords

GLUCOSE SENSORS;

CLINICAL APPLICATION; GLUCOSE MEASUREMENTS; GLUCOSE MONITORING SYSTEM; GLUCOSE SENSING;

GLUCOSE;

EID: 84945917819     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470567319.ch1     Document Type: Chapter

References (66)

1. Papaspyros NS. The History of Diabetes Mellitus, 2nd edn. Georg Thieme Verlag, Stuttgart, 1964.
2. Bernard C. Leçons sur Le Diabete et La Glycogenese Animale. J.-B. Balbìere et Fils, Paris, 1877, p. 95ff.
3. Joslin EP. Apollinaire Bourchardat. Diabetes 1952, 1, 490-491. See also: Bouchardat A. De la glucosurie ou Diabete sucŕe son traitement hygíenique. Libraire Germer Baillìere, Paris, 1883.
4. Cass AEG, Davis G, Francis GD, Hill HAO, Aston WJ, Higgins IJ, Plotkin EV, Scott LD, Turner AP. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Analytical Chemistry 1985, 56, 667-671.
5. Clark LC, Lyons C. Electrode systems for continuous monitoring during cardiovascular surgery. Annals of the New York Academy of Sciences 1962, 102, 29-35.
6. Updike SJ, Hicks GP. The enzyme electrode. Nature 1967, 214, 986-988.
7. Clemens AH, Chang PH, Myers RW. The development of biostator, a glucose controlled insulin infusion system (GCIIS). Hormone Metabolism Research Supplement Series (Blood Glucose Monitoring) 1977, 7, 23-33.
8. Fogt EJ, Dodd LM, Jenning EM, Clemens AH. Development and evaluation of a glucose analyzer for a glucose-controlled insulin infusion system (Biostator). Clinical Chemistry 1978, 24, 1366-1372.
9. Heinemann L, Ampudia-Blasco FJ. Glucose clamps with the Biostator: a critical reappraisal. Hormone Metabolism Research 1994, 26, 579-583.
10. Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H. Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet 1982, 2, 1129-1131.
11. Fischer U, Ertle R, Abel P, Rebrin K, Brunstein E, Hahn von Dorsche H, Freyse EJ. Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetologia 1987, 30, 940-945.
12. Rebrin K, Fischer U, von Woedtke T, Abel P, Brunstein E. Automated feedback control of subcutaneous glucose concentration in diabetic dogs. Diabetologia 1989, 32, 573-576.
13. Fischer U, Rebrin K, von Woedtke T, Abel P. Clinical usefulness of the glucose concentration in subcutaneous tissue: properties and pitfalls of electrochemical biosensors. Hormone Metabolism Research 1994, 26, 515-522.
14. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes 1990, 39, 1519-1526.
15. Diabetes Complications and Control Trial (DCCT) Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329, 1993, 977-986.
16. Hirsch IB, Brownlee M. Should minimal glucose variability become the gold standard of glycemic control? Journal of Diabetes and its Complications 2005, 19, 178-181.
17. Poitout V, Moatti-Sirat D, Reach G, Zhang Y, Wilson GS, Lemonnier F, Klein JC. A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue, and a wearable control unit. Diabetologia 1993, 36, 658-663.
18. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987, 10, 622-628.
19. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technology & Therapeutics 2000, 2, 49-56.
20. Wentholt IM, Vollebrecht MA, Hart AA, Hoekstra JB, DeVries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type I diabetic patients. Diabetes Care 2005, 28, 2871-2876.
21. Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. Journal of the American Medical Association 1999, 282, 1839-1844.
22. TM with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005, 28, 1101-1106.
23. Buckingham B, Block J, Burdick J, Kalajian A, Kollman C, Choy M, Wilson DM, Chase P. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technology and Therapeutics 2005, 7, 440-447.
24. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor. Diabetes Care 2006, 2, 44-50.
25. Kovatchev BP, Gonder-Frederick LA, Linda A, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004, 27, 1922-1928.
26. Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzheimer SA. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007, 30, 59-64.
27. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002, 25, 347-352.
28. Kapitza C, Lodwig V, Obermaier K, Wientjes K, Jan C, Hoogenberg K, Jungheim K, Heinemann L. Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technology and Therapeutics 2003, 5, 609-614.
29. Yan J, Springsteen G, Deeter S, Wang B. The relationship between pKa, pH and binding constants in the interaction between boronic acids and diols: it is not as simple as it seems. Tetrahedron 2004, 60, 11205-11209.
30. Aslan K, Lakowicz JR, Geddes CD. Tunable plasmonic glucose sensing based on the dissociation of ConA-aggregated dextran-coated gold colloids. Analytica Chimica Acta 2004, 517, 139-144.
31. Alexeev V, Das S, Finegold DN, Grabowski J, Somayajula K, Asher SA. Photonic crystal glucose sensing material for non-invasive monitoring of glucose in tear fluid. Clinical Chemistry 2004, 50, 2352-2366.
32. Arnold MA, Small GW. Noninvasive glucose sensing. Analytical Chemistry 2005, 77, 5429-5439.
33. Weiss R, Yegorchikov Y, Shusterman A, Raz I. Noninvasive continuous glucose monitoring using photoacoustic technology: results from the first 62 subjects. Diabetes Technology and Therapeutics 2007, 9, 68-74.
34. Mano N, Mao F, Heller A. On the parameters affecting the characteristics of the ''wired'' glucose anode. Journal of Electroanalytical Chemistry 2005, 574, 347-357.
35. Heller A. Electrical connection of enzyme redox centers to electrodes. Journal of Physical Chemistry 1992, 96, 3579-3587.
36. Heller A. Implanted electrochemical sensors for the management of diabetes. Annual Review of Biomedical Engineering 1999, 1, 153-175.
37. Krauss CJ, Spinks JWT. Temperature coefficients for self-diffusion in solution. Canadian Journal of Chemistry 1954, 32, 71-78.
38. Gutfreund H. Kinetics for the Life Sciences: Receptors, Transmitters and Catalysts, Cambridge University Press, New York, 1995, p. 234.
39. Csöoregi E, Quinn CP, Schmidtke DW, Lindquist SE, Pishko MV, Ye L, Katakis I, Hubbell JA, Heller A. Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. Analytical Chemistry 1994, 66, 3131-3138.
40. Chen X, Matsumoto N, Hu Y, Wilson GS. Electrochemically-mediated electrodeposition/ electropolymerization to yield a glucose microbiosensor with improved characteristics. Analytical Chemistry 2002, 74, 368-372.
41. Matsumoto N, Chen X, Wilson GS. Fundamental studies of glucose oxidase deposition on a Pt electrode. Analytical Chemistry 2002, 74, 362-367.
42. Zhang Y, Wilson GS. Electrochemical oxidation of hydrogen peroxide on platinum and platinum/iridium electrodes in physiological buffer and its applicability to hydrogen peroxide-based biosensors. Journal of Electroanalytical Chemistry 1993, 345, 253-271.
43. Hall SB, Khudaish EA, Hart AL. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part I. An adsorption-controlled mechanism. Electrochimica Acta 1998, 43, 579-588.
44. Hall SB, Khudaish EA, Hart AL. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part V. Inhibition by chloride. Electrochimica Acta 45, 2000, 3573-3579.
45. Choleau C, Dokladal P, Klein JC, Ward WK, Wilson GS, Reach G. Prevention of hypoglycemia using risk assessment with a continuous glucose monitoring system. Diabetes 51, 2002, 3263-3273.
46. Bergman RN. Minimal model: perspective from 2005. Hormone Research 2006, 64 (Suppl. 3), 8-15.
47. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. American Journal of Physiology. Endocrinology and Metabolism 2000, 278, E716-E728.
48. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003, 26, 2405-2409.
49. Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, Horwitz DL. Rapid changes in postprandial blood blouse produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 2002, 25, 961-964.
50. Lowry JP, O'Neill RD. Homogeneous mechanism of ascorbic acid interference in hydrogen peroxide detection at enzyme-modified electrodes. Analytical Chemistry 1992, 64, 453-456.
51. Geise RJ, Adams JM, Barone NJ, Yacynych AM. Electropolymerized films to prevent interferences and electrode fouling in biosensors. Biosensors & Bioelectronics 1991, 6, 151-160.
52. Sasso SV, Pierce RJ, Walla R, Yacynych AM. Electropolymerized 1, 2-diaminobenzene as a means to prevent interferences and fouling and to stabilize immobilized enzyme in electrochemical biosensors. Analytical Chemistry 1990, 62, 1111-1117.
53. Craig JD, O'Neill RD. Electrosynthesis and permselective characterization of phenolbased polymers for biosensor applications. Analytica Chimica Acta 2003, 495, 33-43.
54. Chen X, Hu Y, Wilson GS. Glucose microbiosensor based on alumina sol-gel matrix/ electropolymerized composite membrane. Biosensors & Bioelectronics 2002, 17, 1005-1013.
55. Thoḿe-Duret V, Gangnerau MN, Zhang Y, Wilson GS, Reach G. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabete et Ḿetabolisme 1996, 22, 174-178.
56. Gifford R, Kehoe JJ, Barnes SL, Kornilayev BA, Alterman MA, Wilson GS. Protein interactions with subcutaneously-implanted biosensors. Biomaterials 2006, 27, 2587-2598.
57. Bindra DS. Development of potentially implantable glucose sensors. PhD dissertation, University of Kansas, 1990.
58. Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NAJM, Nolte RJM, Lutterman JA, Van Hovell SWFM, Van der Gaag A. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. Journal of Biomedical Materials Research 2000, 54, 69-75.
59. Reach G, Klein JC.Unpublished results, 1996.
60. Choleau C, Klein JC, Reach G, Aussedat B, Demaria-Pesce V, Wilson GS, Gifford R, Ward WK. Calibration of a subcutaneous amperometric glucose sensor. Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current. Biosensors & Bioelectronics 2002, 17, 641-646.
61. Choleau C, Klein JC, Reach G, Aussedat B, Demaria-Pesce V, Wilson GS, Gifford R, Ward WK. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method. Biosensors & Bioelectronics 2002, 17, 647-654.
62. Clarke WL, Anderson A, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005, 28, 2412-2417.
63. Klonoff DC. The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic and hyperglycemic ranges. Diabetes Care 2004, 27, 834-836.
64. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005, 28, 1231-1239.
65. Gifford R, Batchelor MM, Lee Y, Gokulrangan G, Meyerhoff ME, Wilson GS. Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. Journal of Biomedical Materials Research Part A 2005, 75A, 755-766.
66. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000, 23, 208-214.